StockNews.com assumed coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a research note issued on Thursday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Price Performance
SRNE opened at $0.00 on Thursday. Sorrento Therapeutics has a one year low of $0.00 and a one year high of $0.25.
Sorrento Therapeutics Company Profile
Want More Great Investing Ideas?
See Also
- Five stocks we like better than Sorrento Therapeutics
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- What a Trump Win Looks Like for the Market Now and Into 2025
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop
- Stock Analyst Ratings and Canadian Analyst Ratings
- Macro Headwinds Send Microchip Technology Stock to the Buy Zone
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.